Search Results

1 - 10 of 304 items :

  • European Union x
  • Clinical Medicine x
Clear All
Regulatory Requirements for Food Supplements in the European Union and Bulgaria

/07/2002), p. 0051-0057. 4. Duleva V. [Aspects of regulation of food supplements in the European Union. National Center of Public Health and Analyses], Sofia, 2013 (Article in Bulgarian). 5. FDA. Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues. Retrieved January 15, 2013, from http://www.fda.gov/food/guidancecomplianceregulatoryinformation/guidancedocuments/dietarysupplements/ucm257563.htm .; 2011. 6. European Food Safety Authority. E. Compendium of botanicals reported to contain naturally occurring

Open access
Strengthening of the Blood Safety System in the National Blood Transfusion Service - Implementation of the European Union IPA Project - at the Institute for Transfusion Medicine of the Republic of Macedonia

References 1. WHO: Blood Transfusion Safety. http://www.who.int/bloodsafety/en/ 2. Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. [Official Journal of European Union, L33 of 08/02/2003] 3. Commission Directive 2005/62/EC of 30 September 2005 implementing Directive 2002/98/EC of the European

Open access
Selected determinants of the professional identity of dietitian in the context of legal regulations on the practice of dietitian in Poland and the European Union

położnej podstawowej opieki zdrowotnej (Dz. U. z 2016 r., poz. 1567). 27. bda.uk.com [Internet] British Dietetic Association, Birmingham; [cited 2018 Jul 20] Available from: https://www.bda.uk.com/improvinghealth/healthprofessionals/cost_benefit_of_dietitians . 28. Directive 2005/36/EC of the European Parliament and of the Council of 7 September 2005 on the recognition of professional qualifications, article 3, point 1(a). Official Journal of the European Union; L 255/22 30.9.2005. 29. http://www.sejm.gov.pl/ [Internet] Sejm Rzeczypospolitej Polskiej

Open access
Research on Approaches for Regulation of the “Off-label” use of Medicinal Products in the European Union

at: http://www.gmc-uk.org/guidance/ethical_guidance/14316.asp . Last access: 2016/10/27. 10. Guideline on good pharmacovigilance practices (GVP), Annex I – Definitions (Rev 3) Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/05/WC500143294.pdf . Last access: 2016/10/27. 11. Legal mandate, procedures – Federal Joint Committee. Available at: http://www.english.g-ba.de/legalmandate/ . Last access: 2016/10/27. 12. Lenk, C., G. Duttge. Ethical and legal framework and regulation for off-label use: European

Open access
The Incidence of Adolescent Pregnancy at Clinic of Gynecology and Obstetrics of Clinical Center Kragujevac

/infection on preterm delivery. Vojnosanit Pregl. 2008;65(4):273–280. 11. Славка, Д. Г. (2000.). Антропометријски нормативи новорођенчади. Београд: Медицински факултет универзитета у Београду. 12. D Silva AAM, Simeos VMF, Barbieri MA, Betioll H, Lamz Filho F, Coimbra LC and Alves. Young maternal age and preterm birth, Paediatric and Perinatal Epidemiology. 2003; 17(4) :332-339 13. Part К, Moreau C, Donati S, Gissler M, Fronteira I, Karro H. Teenage pregnancies in the European Union in the context of legislation and youth sexual and reproductive health

Open access
Perceived work ability index of public service employees in relation to ageing and gender: A comparison in three European countries

differences in three cohorts in three European countries. 2 Methods 2.1 Study Population and Design A longitudinal study was performed between January and September 2018 among public service professionals in Spain, Monte Negro and Bosnia and Herzegovina (B&H). We assessed the influence of ageing and gender to work ability among public sector employees (in three various European countries: Spain (country in Europe Union), Monte Negro and B&H (countries in South East Europe region). We compared national and gender differences of work ability in older employees aged

Open access
Current regulatory and market environment for biosimilars in Serbia

References 1. Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Schellekens H, Leufkens HG, Egberts AC. Safety-related regulatory actions for biologicals approved in the United States and the European Union. J Am Med Assoc 2008; 300: 1887-96. 2. EvaluatePharma® World Preview to 2012, 6 June 2008. 3. Kresse GB. Biosimilars - science, status and strategic perspective. Eur J Pharm Biopharm 2009; 72: 479-86. 4. Grabowski HG, Ridley DB, Schulman KA. Entry and competition in generic biologics

Open access
Trends in the Acute Hepatitis B and Acute Hepatitis C in Bulgaria

ABBREVIATIONS USED IN THIS ARTICLE HBV hepatitis B virus HCV hepatitis C virus EU European Union NCIPD National Center of Infectious and Parasitic Diseases NCPHA National Center of Public Health and Analyses EEA European Economic Area ECDC European Centre for Disease Prevention and Control SPSS Statistical Package for the Social Sciences IBM International Business Machines REFERENCES 1. National Center of Infectious and Parasitic Diseases (NCIPD), Sofia, Bulgaria. [Annual reports of the infectious diseases in Bulgaria (2000

Open access
Traditional Chinese medicine and Ayurvedic medicine products: a possible cause for concern – the Polish perspective

. 2015;173:318-29. 7. Fan TP, Deal G, Koo HL, et al. Future development of global regulations of Chinese herbal products. J Ethnopharmacol. 2012;140:568-86. 8. Sammons HM, Gubarev MI, Krepkova LV, et al. Herbal medicines: challenges in the modern world. Part 2. European Union and Russia. Expert Rev Clin Pharmacol. 2016;9:1117-27. 9. Wiesener S, Falkenberg T, Hegyi G, et al. Legal status and regulation of CAM in Europe. Part I – CAM regulations in the European countries. CAMbrella Final Report Work Package 2. (cited 2018 Feb 2). [ http

Open access
Access to Ethics Committees in Bulgaria – Possibility or Probability

REFERENCES 1. Charter of Fundamental Rights of the European Union, 2012 / C 326/02. 2. Constitution of the Republic of Bulgaria, State Gazette No. 56/13. 07.1991. 3. Law on Medical Establishments, Prom. SG. No. 62 of 9 July 1999. 4. Law on Medicinal Products in Human Medicine, Prom. SG. no. 31 of 13 April 2007. 5. Code of professional ethics of physicians in Bulgaria – issued by the Ministry of Health – Prom. SG. No. 79 of 29 September, 2000, amend. SG 85 of 28 September 2013.

Open access